Emerging novel antifungal agents

Drug Discovery Today

Volumn 5, Issue 1, 2000, Pages 25-32

  Fostel, Jennifer M ^a   Lartey, Paul A ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOCYCLOPENTANECARBOXYLIC ACID; ANTIFUNGAL AGENT; ARTHRICHITIN; AUREOBASIDIN; BE 31405; CITRININ; CORYNECANDIN; GALBONOLIDE A; GALBONOLIDE B; GM 222712; GM 237354; GR 135402; KHAFREFUNGIN; L 760262; L 770715; LL 15G256; MER WF 3010; SORDARIN; UK 2A; UK 3A; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; DRUG ACTIVITY; DRUG INACTIVATION; DRUG PROTEIN BINDING; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; REVIEW;

EID: 0033977772     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(99)01430-0     Document Type: Review

References (52)

1. P.A. Lartey C.M. Moehle Recent advances in antifungal agents J.J. Plattner Annual Reports in Medicinal Chemistry 1997 Academic Press 151 160
2. G.K. Abruzzo Evaluation of the echinocandin antifungal MK-0991 (L-743,872): Efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis Antimicrob. Agents Chemother. 41 1997 2333 2338
3. G.G. Zhanel In vitro activity of a new echinocandin, LY-303366, against systemic isolates of Candida species , Cryptococcus neoformans , Blastomyces dermatitidis , and Aspergillus species Antimicrob. Agents Chemother. 41 1997 863 865
4. G. 4 Gunawardana Corynecandin: a novel antifungal glycolipid from Coryneum modonium J. Antibiot. 50 1997 884 886
5. R. Kaneto Mer-WF3010. A new member of the papulacandin family. 1. Fermentation, isolation and characterization J. Antibiot. 46 1993 247 250
6. M. Jackson Fusacandins A and B; Novel antifungal antibiotics of the papulacandin class from Fusarium sambucinum . I. Identity of the producing organism, fermentation and biological activity J. Antibiot. 48 1995 608 613
7. C.M. Yeung Preparation and antifungal activity of fusacandin analogs: C-6′ sidechain esters Bioorg. Med. Chem. Lett. 6 1996 819 822
8. P.A. Lartey Challenges in antibacterial and antifungal drug discovery F. Awouters XIVth International Symposium on Medicinal Chemistry 1997 Elsevier 205 218
9. E.K.S. Vijayakumar Arthrichitin. A new cell wall active metabolite from Arthrinium phaeospermum J. Org. Chem. 61 1996 6591 6593
10. D. Abbanat Cell wall active antifungal compounds produced by the marine fungus Hypoxylon oceanicum LL-15G256. I. Taxonomy and fermentation J. Antibiot. 51 1998 296 302
11. G. Schlingmann Cell wall active antifungal compounds produced by the marine fungus Hypoxylon oceanium LL-15G256. II. Isolation and structure determination J. Antibiot. 51 1998 303 316
12. D. Albaugh Cell wall active antifungal compound produced by the marine fungus Hypoxylon oceanicum LL-15G256. III. Biological properties of 15G256γ J. Antibiot. 51 1998 317 322
13. G.P. Belfield M.F. Tuite Translation elongation factor 3: A fungus specific translation factor? Mol. Microbiol. 9 1993 411 418
14. von D. Hauser H.P. Sigg Isolierung und Abbau von Sordarin. 1. Mitteilung über Sordarin Helv. Chim. Acta 54 1971 1178 1190
15. M.C. Justice Elongation factor 2 as a novel target for selective inhibition of fungal protein synthesis J. Biol. Chem. 273 1998 3148 3151
16. J.M. Dominguez Sordarins: A new class of antifungals with selective inhibition of the protein synthesis elongation cycle in yeasts Antimicrob. Agents Chemother. 42 1998 2274 2278
17. O.S. Kinsman Isolation and characterization of an antifungal antibiotic (GR 135402) with protein synthesis inhibition J. Antibiot. 51 1998 41 49
18. H. Okada BE-31405, a new antifungal antibiotic produced by Penicillium minioluteum . I. Description of producing organism, fermentation, isolation, physico-chemical and biological properties J. Antibiot. 51 1998 1081 1086
19. J.M. Dominguez J.J. Martin Identification of elongation factor 2 as the essential protein targeted by sordarins in Candida albicans Antimicrob. Agents Chemother. 42 1998 2279 2283
20. L. Capa Translation elongation factor 2 is part of the target for a new family of antifungals Antimicrob. Agents Chemother. 42 1998 2694 2699
21. M.C. Justice Mutations in ribosomal protein L10e confer resistance to the fungal-specific eukaryotic elongation factor 2 inhibitor sordarin J. Biol. Chem. 274 1999 4869 4875
22. M.G. Gomez-Lorenzo J.F. Garcia-Bustos Ribosomal P-protein stalk function is targeted by sordarin antifungals J. Biol. Chem. 273 1998 25041 25044
23. E. Herreros Sordarins: In vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii , and filamentous fungi Antimicrob. Agents Chemother. 42 1998 2863 2869
24. M. Konishi Cispentacin, a new antifungal antibiotic. 1. Production, isolation, physico-chemical properties and structure J. Antibiot. 42 1989 1749 1755
25. T. Iwamoto FR 109615, a new antifungal antibiotic from Streptomyces setonii . Taxonomy, fermentation, isolation, physicochemical properties and biological activity J. Antibiot. 43 1990 1 7
26. K. Ziegelbauer Molecular mode of action of the antifungal beta-amino acid BAY 10-8888 Antimicrob. Agents Chemother. 42 1998 2197 2205
27. J.O. Capobianco Anti- Candida activity of cispentacin: The active transport by amino acid permeases and possible mechanisms of action Biochem. Biophys. Res. Commun. 190 1993 1037 1044
28. H. Ohki Synthesis and antifungal activity of FR 109615 analogs J. Antibiot. 44 1991 546 549
29. T. Oki Cispentacin, a new antifungal antibiotic. II. In vitro and in vivo antifungal activities J. Antibiot. 42 1989 1756 1762
30. M. Fujiu Azoxybacillin, a novel antifungal agent produced by Bacillus cereus NR2991 J. Antibiot. 47 1994 833 835
31. Y. Aoki A new methionine antagonist which has antifungal activity: Mode of action J. Antibiot. 47 1994 909 915
32. Y. Aoki Antifungal azoxybacillin exhibits activity by inhibiting gene expression of sulfite reductase Antimicrob. Agents Chemother. 40 1996 127 132
33. J. Ohwada Synthesis and structure–activity relationships of a novel antifungal agent azoxybacillin Chem. Pharm. Bull. 42 1994 1703 1705
34. M.M. Nagiec Sphingolipid synthesis as a target for antifungal drugs J. Biol. Chem. 272 1997 9809 9817
35. K. Takesako Aureobasidins, new antifungal antibiotics. Taxonomy, fermentation, isolation, and properties J. Antibiot. 44 1991 919 924
36. K. Ikai Structure of aureobasidin A J. Antibiot. 44 1991 925 933
37. T. Kurome Total synthesis of an antifungal cyclic depsipeptide aureobasidin A Tetrahedron 52 1996 4327 4346
38. M.J. Rodriguez Relationship between structure and biological activity of novel R 106 analogs J. Antibiot. 49 1996 386 389
39. T. Kurome Syntheses of antifungal aureobasidin A analogs with alkyl chains for structure–activity relationship J. Antibiot. 51 1998 359 367
40. A. Ogawa Role of ABC transporters in aureobasidin A resistance Antimicrob. Agents Chemother. 42 1998 755 761
41. T. Kurome Aureobasidins as new inhibitors of P-glycoprotein in multidrug resistant tumor cells J. Antibiot. 51 1998 353 358
42. T. Takasu Rustmicin, a new macrolide antibiotic active against wheat stem rust fungus J. Antibiot. 38 1985 1806 1809
43. H. Achenbach Galbonolides A and B – Two new non-glycosidic antifungal macrolides from Streptomyces galbus Tetrahedron Lett. 26 1985 6167 6170
44. Y. Abe Neorustimicin A, a new macrolide antibiotic active against wheat stem fungus J. Antibiot. 38 1985 1810 1812
45. G.H. Harris Inhibition of fungal sphingolipid biosynthesis by rustmicin, galbonolide B and their new 21-hydroxy analogs J. Antibiot. 51 1998 837 844
46. S. Mandala Rustmicin, a potent antifungal agent, inhibits sphingolipid synthesis at inositol phosphoceramide synthase J. Biol. Chem. 273 1998 14942 14949
47. S.M. Mandala Khafrefungin, a novel inhibitor of sphingolipid synthesis J. Biol. Chem. 51 1997 32709 32714
48. M. Ueki UK-2A, B, C and D, novel antifungal antibiotics from Streptomyces sp. 517-02. I. Fermentation, isolation, and biological properties J. Antibiot. 49 1996 639 643
49. M. Hanafi UK-2A, B, C and D, novel antifungal antibiotics from Streptomyces sp. 517-02. II. Structural elucidation J. Antibiot. 49 1996 1226 1231
50. M. Ueki UK-3A, a novel antifungal antibiotic from Streptomyces sp. 517-02: Fermentation, isolation, structural elucidation and biological properties J. Antibiot. 50 1997 551 555
51. M. Ueki M. Taniguchi The mode of action of UK-2A and UK-3A, novel antifungal antibiotics from Streptomyces sp. 517-02 J. Antibiot. 50 1997 1052 1057
52. 3 on cytotoxic activity and reactive oxygen species generation in LLC-PK1 cells J. Antibiot. 52 1998 480 484